ACMT will present two full-day Satellite Sessions on Thursday, April 11, preceding our 2019 Annual Scientific Meeting (April 12-14). Satellite Sessions focus on contemporary and emerging issues within Medical Toxicology.
Legal Cannabis: Medical, Toxicological and Public Health Implications
- Matthew Fedoruk, PhD, Senior Managing Director of Science & Research, US Anti-Doping Agency
- Mike Lynn, MD, CEO & Co-Founder, Hound Labs
New Frontiers in Medical Toxicology: Pharmacogenomics and Precision Medicine
- Russ B. Altman, MD, PhD, Professor of Bioengineering, Genetics, Medicine, and Biomedical Data Science, Stanford University; Director, Biomedical Informatics Training Program
- Shaun R. Opie, PhD, Co-founder & CSO, Vantari Genetics